Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastoma-Reference-Cited by-同舟云学术

Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastoma

Published:2021-08 Issue: Volume:161 Page:140-147
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

He Ling,Bhat Kruttika,Ioannidis Angeliki^ORCID,Zhang Le,Nguyen Nhan T.^ORCID,Allen Joshua E.,Nghiemphu Phioanh Leia,Cloughesy Timothy F.,Liau Linda M.,Kornblum Harley I.,Pajonk Frank^ORCID

Funder

National Cancer Institute

University of California, Los Angeles

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference43 articles.

1. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review;Laperriere;Radiother Oncol,2002

2. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy;Chan;J Clin Oncol,2002

3. Overcoming therapeutic resistance in glioblastoma: the way forward;Osuka;J Clin Invest,2017

4. Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment;Dirkse;Nat Commun,2019

5. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence;Auffinger;Expert Rev Neurother,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma;Molecular Therapy: Oncology;2024-09

2. Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1;Cancer Research Communications;2024-06-25

3. Radiation-Induced Cellular Plasticity: A Strategy for Combatting Glioblastoma;2024-05-16

4. Metabolic vulnerability of cancer stem cells and their niche;Frontiers in Pharmacology;2024-04-10

5. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models;Neuro-Oncology;2024-03-30